Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
1467
-
Total 13F shares, excl. options
-
1.07B
-
Shares change
-
+43.9M
-
Total reported value, excl. options
-
$42B
-
Value change
-
+$1.7B
-
Put/Call ratio
-
0.91
-
Number of buys
-
695
-
Number of sells
-
-629
-
Price
-
$39.31
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2016
1,600 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2016.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,467 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07B shares
of 1.74B outstanding shares and own 61.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (97.8M shares), STATE STREET CORP (60.3M shares), BlackRock Institutional Trust Company, N.A. (38.9M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (36.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (29.5M shares), Bank of New York Mellon Corp (29.3M shares), BlackRock Fund Advisors (22.8M shares), GOLDMAN SACHS GROUP INC (22.1M shares), WELLS FARGO & COMPANY/MN (21.4M shares), and NORTHERN TRUST CORP (20.6M shares).
This table shows the top 1467 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.